Introduction {#s1}
============

Osteoarthritis (OA) is characterised by breakdown of the articular cartilage, abnormal bone remodelling, osteophytosis and, in some cases, low-degree synovitis. It is a leading cause of chronic disability, yet we still do not have a cure. Although generally efficacious, joint replacement does not live up to patient expectation in up to 30% of cases,[@R1] it has a limited life span, often requiring complex revisions, and is not suitable for the ever-growing population of younger patients with early OA who have an active lifestyle.

WNT signalling is involved in several biological processes including joint formation during embryonic skeletogenesis and joint homeostasis and disease in postnatal life.[@R2]

WNTs are a family of 19 highly conserved morphogens that signal through several different pathways. In the β-catenin-dependent (or canonical WNT) pathway, engagement of WNTs with their receptors results in the accumulation and nuclear translocation of β-catenin and transcriptional activation of target genes.[@R12] The non-canonical pathways are less understood and involve Ca^2+^ signalling, phosphatidylinositol-4,5-biphosphate 3-kinase (PI3K) and activation of cjun N-terminal kinase (JNK).[@R13]

Although genetic studies in humans and experimental studies in animals provide overwhelming evidence for the role of WNT signalling in cartilage homeostasis and OA, the mechanisms underpinning these functions are still poorly understood. It has been shown that a delicate balance of WNT activity is needed for cartilage homeostasis as both repression[@R7] and constitutive activation[@R8] of the β-catenin pathway lead to cartilage breakdown. Similarly, excessive WNT activation following loss of function of the WNT inhibitor Frizzled related protein (FRZB) resulted in increased susceptibility to OA in mice[@R14] and in humans,[@R15] but the excessive WNT suppression due to the tumour necrosis factor-dependent expression of DKK1 in inflammatory arthritis also results in cartilage and bone destruction.[@R16] [@R17] How this balance is achieved within the joint is unclear.

WNT16 is expressed in the joint interzones during joint formation and in the superficial cells of the articular cartilage postnatally.[@R4] [@R5] In adult cartilage, it is not expressed in normal conditions, but it is rapidly upregulated following injury or in OA.[@R18]

We demonstrate that WNT16 upregulation following injury protects cartilage from breakdown following destabilisation of the medial meniscus (DMM). This effect is likely mediated through upregulation of lubricin, an essential joint lubricant that protects chondrocytes from shear stresses and cartilage from mechanically induced breakdown.[@R19] We also show that WNT16 is a weak activator of canonical WNT signalling in chondrocytes and that this is required for the upregulation of lubricin. However, in the presence of other more potent canonical WNT ligands, WNT16 acts as an inhibitor, preventing excessive activation of the pathway, which is known to result in cartilage damage.

Methods {#s2}
=======

Surgical procedure {#s2b}
------------------

DMM was performed as previously described[@R20] [@R21] on 10-week-old male *wnt16^−/−^* or wild-type 129/Sv mice (cousins). The contralateral knees were either sham-operated or non-operated as an internal control. The mice were sacrificed by cervical dislocation at 2 days, 7 days or 8 weeks post surgery.

Histological analysis and OA scoring {#s2c}
------------------------------------

Histological processing was performed as discussed elsewhere[@R21] and scored using the Osteoarthritis Research Society International (OARSI) scoring system by two independent investigators.[@R22] All images were taken using the same settings on an Olympus BX61 microscope.

Immunohistochemistry and TUNEL staining {#s2d}
---------------------------------------

Immunohistochemistry and apoptosis detection were performed as described in refs [@R21], [@R23], [@R24] and detailed in [supplementary materials](#SM1){ref-type="supplementary-material"}.
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Gene expression analysis {#s2e}
------------------------

DMM or control joints were detached from the animals immediately after death and the soft tissues removed under a dissecting microscope. The articular surface of the femoral condyles and the tibial plateaus was isolated at the level of the growth plate using a scalpel and homogenised in 1 mL of Trizol (Life Technologies).

In vitro gene expression analysis was performed on primary human or bovine articular chondrocytes (BACs) obtained from young animals (isolated as described in ref. [@R23]) and on superficial zone cell (SZC) isolated from the knees of neonatal mice.[@R5] Cells were stimulated with WNT16, WNT3a or DKK1 recombinant proteins (R&D Systems) for 24 h before phosphate buffered saline (PBS) wash and addition of 1 mL of Trizol (Invitrogen) for RNA isolation and Q-PCR analysis.[@R23] A list of the primers used can be found in online [supplementary table](#SM1){ref-type="supplementary-material"} S1.

SUPER8XTOPFlash reporter assay {#s2f}
------------------------------

The chondrocytes were co-transfected with SUPER8XTOPFlash TCF/LEF-firefly luciferase reporter plasmid and CMV-Renilla luciferase plasmid using JetPRIME transfection reagent (Polyplus). The cells were stimulated for 48 h replacing the medium after 24 h before luciferase activity was measured using the Dual luciferase Reporter assay system (Promega).

Xenopus assay {#s2g}
-------------

Xenopus embryos were injected ventrally with either 0.02 ng/μL wnt16 or 0.002 ng/μL wnt8 RNA at the four-cell stage and left for 2 days to develop before analysis.

Statistical analysis {#s2h}
--------------------

Parametric data were compared with the t test, non-parametric data with the Wilcoxon--Mann--Whitney test. For multiple comparisons, the analysis of variance or Kruskal--Wallis test, including the appropriate post test, was used. p Values \<0.05 were considered significant: \*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001.

Results {#s3}
=======

WNT16 is transiently upregulated in cartilage following DMM {#s3a}
-----------------------------------------------------------

We reported that the embryonic joint interzone marker WNT16 is re-expressed in the adult human articular cartilage following acute injury and in OA.[@R18]

We first confirmed that WNT16 was no longer expressed in healthy adult mouse articular cartilage, and that, following DMM, it was upregulated at mRNA and protein level ([figure 1](#ANNRHEUMDIS2015208577F1){ref-type="fig"}). Some upregulation also took place in sham-operated knees, particularly at early time points; however, DMM-operated knees exhibited a greater upregulation at 7 days.

![WNT16 is upregulated in experimental osteoarthritis induced by destabilisation of the medial meniscus (DMM). Wild-type mice received DMM of the left knee and sham operation on the right and were killed at 2 days (C and D), 7 days (E and F) and 8 weeks (G) post surgery. (A) WNT16 mRNA was upregulated in the whole joints of DMM-operated mice compared with sham-operated controls, reaching statistical significance after 7 days. WNT16 protein was undetectable in non-operated knees (B), but was upregulated at 2 days following DMM (C) and, to a lesser extent, following sham operation (D). WNT16 expression was further increased in DMM-operated mice at 7 days (E) and to less of an extent following sham operation (F) (joint tissues labelled as follows: C, cartilage; B, subchondral bone; M, meniscus). After 8 weeks, (G) WNT16 was no longer detected in DMM-operated knees. (H) Isotype negative control at the 2-day time point. N=3 per condition.](annrheumdis-2015-208577f01){#ANNRHEUMDIS2015208577F1}

WNT16-deficient mice have a more severe outcome following surgical induction of OA {#s3b}
----------------------------------------------------------------------------------

To elucidate the role of WNT16 upregulation following joint injury, we generated WNT16 null mice (*wnt16*^−/−^) through deletion of exon 2 by homologous recombination (see online [supplementary figure](#SM1){ref-type="supplementary-material"} S1A). Successful recombination was confirmed by PCR (see online [supplementary figure](#SM1){ref-type="supplementary-material"} S1B). The mutants were backcrossed for nine generations in the 129/Sv genetic background where no differences were detected in cartilage morphology (see online [supplementary figure](#SM1){ref-type="supplementary-material"} S1C,D). At 18 months of age, both wild-type and *wnt16^−/−^* animals developed minor superficial cartilage irregularities in keeping with the strain. In the 129/Sv genetic background, we did not detect differences in bone structure/morphology as shown by Micro-CT at the vertebral bodies (see online [supplementary figure](#SM1){ref-type="supplementary-material"} S2) and the femoral epiphyses (see online [supplementary figure](#SM1){ref-type="supplementary-material"} S3). The thickness of the subchondral bone was also comparable (see online [supplementary figure](#SM1){ref-type="supplementary-material"} S3C). However, in keeping with a previous report,[@R25] in the DBA/1 background, spontaneous fractures occurred in *wnt16^−/−^* mice (not shown), suggesting that the severity of the previously reported bone phenotype is strain dependent. These results suggest that WNT16 is not required for the normal development and growth of synovial joints and, in resting conditions, the absence of WNT16 does not predispose to OA.

Standard animal husbandry conditions are not always representative of normal life, where, in humans, cartilage injuries are common.[@R26] Since WNT16 is upregulated in cartilage after injury[@R18] in humans and mice, we investigated whether the upregulation of this molecule has a role in the adaptive responses that restore cartilage homeostasis following injury. To study this, we induced experimental OA in 10-week-old *wnt16^−/−^* and wild-type controls (129/Sv background) by DMM.[@R20]

Eight weeks following DMM, *wnt16^−/−^* mice developed more severe OA compared with wild-type controls as assessed by histological scoring[@R22] [@R27] ([figure 2](#ANNRHEUMDIS2015208577F2){ref-type="fig"}A, B) and histomorphometrical comparison of the intensity of safranin O staining ([figure 2](#ANNRHEUMDIS2015208577F2){ref-type="fig"}C). The histomorphometry is described in online [supplementary figure](#SM1){ref-type="supplementary-material"} S4. An independent experiment in mice at the fifth backcross into the 129/Sv phenotype yielded similar results (data not shown). We did not detect statistically significant differences in the expression of the aggrecanases ADAMTS-4/-5 or in the detection of aggrecan neoepitopes generated by aggrecanase or matrix metalloproteases (MMP) cleavage (see online [supplementary figure](#SM1){ref-type="supplementary-material"} S5).

![Wnt16^−/−^ mice are more susceptible to instability-induced osteoarthritis. The 10-week-old mice (7 wild-type (WT) and 10 wnt16^−/−^ (KO)) were subjected to destabilisation of the medial meniscus and the outcome was compared 8 weeks following surgery. (A) Safranin O staining of the medial compartment of representative sections. (B) OARSI histological score. (C) Intensity of the safranin O in the medial tibial plateau. LF, lateral femur; LT, lateral tibia; MF, medial femur; MT, medial tibia.](annrheumdis-2015-208577f02){#ANNRHEUMDIS2015208577F2}

These results suggest that WNT16 has a homeostatic role that limits the extent of cartilage breakdown following induction of joint instability.

WNT16-deficient mice fail to upregulate the joint lubricant lubricin, following surgical induction of OA {#s3c}
--------------------------------------------------------------------------------------------------------

WNT signalling is essential for the expression of the joint lubricant lubricin.[@R5] Deficiency of *Prg4* (gene encoding for lubricin) in mice and loss of function mutations in humans leads to cartilage breakdown and spontaneous OA due to increased coefficient of friction in the joint.[@R19] *Wnt16^−/−^* and wild-type mice showed similar levels of lubricin under resting conditions; however, 2 days following surgery, wild-type mice, but not *wnt16^−/−^*, upregulated lubricin expression at mRNA and protein level ([figure 3](#ANNRHEUMDIS2015208577F3){ref-type="fig"}A--C).

![Lubricin was upregulated following destabilisation of the medial meniscus (DMM). Wild-type (WT) and wnt16^−/−^ mice were subjected to DMM and killed 2 days thereafter. (A) The joint surface, including the articular cartilage and the subchondral bone, was dissected and processed for gene expression analysis by real-time PCR. Lubricin was upregulated in WT mice but not in wnt16^−/−^ mutants at mRNA level 2 days following DMM (N≥10). (B) At protein level, lubricin staining following DMM was detected in the superficial layer of the articular cartilage and in a region between the intermediate and the deep layer in WT mice. (C) The area of the articular cartilage positive for lubricin staining 2 days following DMM was significantly higher in WT mice (N=4) than in wnt16^−/−^ mice (N=6). (D) WNT16 recombinant protein upregulated lubricin mRNA expression in bovine articular chondrocyte (BAC) at 24 h (N=3). KO, knockout. \*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001.](annrheumdis-2015-208577f03){#ANNRHEUMDIS2015208577F3}

Treatment of primary BACs with recombinant WNT16 was sufficient to upregulate lubricin expression in vitro ([figure 3](#ANNRHEUMDIS2015208577F3){ref-type="fig"}D).

Loss of WNT16 resulted in increased apoptosis in the SZCs of the articular cartilage {#s3d}
------------------------------------------------------------------------------------

Spontaneous OA development in *Prg4*-deficient mice is associated with chondrocyte apoptosis.[@R19] Two days following DMM, when WNT16 is upregulated in wild-type mice, WNT16-deficient mice developed increased apoptosis. This selectively occurred in the superficial layer of the cartilage and, as expected, was particularly increased in the medial compartment of the knee where the osteoarthritic lesions are most severe ([figure 4](#ANNRHEUMDIS2015208577F4){ref-type="fig"}A, B).

![Disruption of WNT16 results in apoptosis of superficial cartilage cells and in the loss of superficial zone molecular markers. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining of representative sections from the medial compartment of the knee of wild-type (WT) and *wnt16^−/−^* mice 2 days after destabilisation of the medial meniscus (DMM) (N=6) (A). The TUNEL staining (shown in red) was superimposed on the Nomarski image for anatomical orientation. Quantification of TUNEL-positive cells in the superficial and deep layers of the articular cartilage within the medial compartment (most affected in DMM) and lateral compartment (mildly or unaffected) (B). Gene expression analysis of superficial zone cells from wnt16^−/−^ mice with or without rescue with exogenous 200 ng/mL recombinant WNT16 (N=4) (C). KO, knockout. \*p\<0.05.](annrheumdis-2015-208577f04){#ANNRHEUMDIS2015208577F4}

As the loss of WNT16 specifically affected apoptosis in the SZCs and as these cells specifically express WNT16 during embryonic and early postnatal development, we explored the effect of WNT16 in the SZC. In adulthood, these cells are considered a specific progenitor cell population within the permanent articular cartilage and are essential for cartilage homeostasis.[@R28] Cells were isolated as previously described from the knees of neonatal mice.[@R5] These cells display a marker profile characterised by expression of WNT16 and lubricin, and low expression of COL2A1, Aggrecan and Matrilin1[@R5] [@R6] (see online [supplementary figure](#SM1){ref-type="supplementary-material"} S6). The remainder of the neonatal epiphysis is prevalently composed of epiphysial chondrocytes that are destined to be replaced by bone, do not express WNT16 and do express Matrilin1.[@R29]

In cultures enriched for SZC from *wnt16^−/−^* mice, recombinant WNT16 upregulated the SZC lineage marker lubricin, downregulated the epiphysial lineage marker Matrilin1 and inhibited the expression of SOX9, which is expressed at higher level in epiphysial chondrocytes compared with SZC ([figure 4](#ANNRHEUMDIS2015208577F4){ref-type="fig"}C).[@R5] This suggested that rather than just upregulating lubricin, WNT16 specifically supports the phenotype marker profile of the SZC.

WNT16 maintains a balanced activation of the canonical pathway {#s3e}
--------------------------------------------------------------

Since canonical WNT signalling supports the phenotype of the superficial zone chondrocytes,[@R5] [@R6] we tested whether WNT16 could activate the canonical WNT pathway in chondrocytes and whether canonical WNT activation was required for lubricin upregulation by WNT16. In keeping with previous reports,[@R3] [@R25] WNT16 concentrations of 200 ng/mL or higher consistently and dose-dependently upregulated Axin2 (a transcriptional target of canonical signalling) in primary human and BACs ([figure 5](#ANNRHEUMDIS2015208577F5){ref-type="fig"}A and online [supplementary figure](#SM1){ref-type="supplementary-material"} S7A).

![WNT16 is a weak activator of the β-catenin-dependent pathway but also limits its activation by other more potent canonical WNTs. WNT16 caused a weak upregulation of the canonical WNT reporter gene Axin2 compared with WNT3a, in human articular chondrocytes (HAC) (N=3 patients, 4 replicates each) (A). Lubricin expression caused by WNT16 stimulation (ng/mL) in HAC (B), and mouse superficial zone cell (SZC) (C), was higher than that caused by WNT3a stimulation. Lubricin expression decreased in the presence of canonical inhibitor DKK1 (100 ng/mL) in mouse SZC (N=4) (C). All at 24 h. Following destabilisation of the medial meniscus (DMM) surgery, wnt16^−/−^ mice had a higher expression of Axin2 mRNA in their joints (D). WNT16 reduced the capacity of WNT3a to activate the SUPER8XTOPFlash reporter assay in HEK293 cells treated with WNT3a, alone and in combination with WNT16 (ng/mL) (N=4) (E and F). *wnt16* inhibited axis duplication caused by *wnt8* in Xenopus laevis (G and H). Embryos were injected ventrally with 0.02 ng/µL *wnt16* or 0.002 ng/µL *wnt8* at the four-cell stage and left for 2 days to develop (n=36--47).](annrheumdis-2015-208577f05){#ANNRHEUMDIS2015208577F5}

Interestingly, although WNT16 was not as efficient as WNT3a at activating the canonical pathway, it caused a larger upregulation of lubricin ([figure 5](#ANNRHEUMDIS2015208577F5){ref-type="fig"}B, C and online [supplementary figure](#SM1){ref-type="supplementary-material"} S7B), which still was partially abolished by the canonical WNT inhibitor DKK1 ([figure 5](#ANNRHEUMDIS2015208577F5){ref-type="fig"}C and online [supplementary figure](#SM1){ref-type="supplementary-material"} S7C).

Since WNT16 could activate the canonical WNT pathway in vitro, we expected that *wnt16^−/−^* mice would display decreased Axin2 upregulation following experimental OA. Surprisingly, WNT16-deficient mice had higher levels of Axin2, indicating a higher level of canonical pathway activation ([figure 5](#ANNRHEUMDIS2015208577F5){ref-type="fig"}D). Since WNT16 is a weak activator of the canonical pathway ([figure 5](#ANNRHEUMDIS2015208577F5){ref-type="fig"}A), we hypothesised that, in vivo, WNT16 could compete with other, more potent, WNTs activated in OA,[@R14] thereby limiting their capacity to disproportionately activate the β-catenin pathway, which is known to result in further cartilage breakdown. To confirm this hypothesis, we investigated whether WNT16 could stunt the WNT3a-induced activation of the canonical pathway. As expected, WNT3a alone dose-dependently activated the SUPER8XTOPFLASH reporter assay ([figure 5](#ANNRHEUMDIS2015208577F5){ref-type="fig"}E), but co-treatment with WNT16 dose-dependently inhibited the WNT3a-induced reporter activity starting from concentrations as low as 50 ng/mL ([figure 5](#ANNRHEUMDIS2015208577F5){ref-type="fig"}E, F).

To investigate whether WNT16 can inhibit the signalling of more potent canonical WNTs in vivo and in different biological contexts, we used the well-established Xenopus assay where injection of a ventral blastomere at the four-cell stage with WNT ligands that activate the canonical WNT pathway induces complete primary axis duplication or a strong hyperdorsalisation.[@R30]

As expected, injection of *wnt8* induced complete axis duplication in the majority of the tadpoles, as defined by complete duplication of the cement gland (yellow arrowhead) ([figure 5](#ANNRHEUMDIS2015208577F5){ref-type="fig"}G, H). Consistent with our data, injection of *wnt16* RNA mostly induced weak hyperdorsalisation, which indicates a very mild activation of the β-catenin pathway. However, co-injection of *wnt16* and *wnt8* resulted in inhibition of the complete axis duplication induced by *wnt8* and in a phenotype resembling that induced by the injection of *wnt16* alone ([figure 5](#ANNRHEUMDIS2015208577F5){ref-type="fig"}G, H).

We propose a model where WNT16 buffers the activation of the canonical WNT pathway, overcoming the activity of more potent canonical WNT ligands such as WNT3a and *wnt8*, and supporting a controlled mild activation of WNT signalling, while preventing the excessive activation mediated by other WNTs ([figure 6](#ANNRHEUMDIS2015208577F6){ref-type="fig"}).

![Cartilage injury causes activation of WNT signalling through downregulation of antagonists such as FRZB and upregulation of several agonists such as WNT16 and WNT8.[@R14] [@R18] WNT16 buffers the canonical WNT activation to homeostatic levels through its capacity to directly support a weak activation and preventing excessive activation induced by other ligands. Excessive canonical WNT activation causes cartilage breakdown by driving inappropriate maturation particularly within the superficial zone progenitor cells,[@R8] [@R18] whereas homeostatic levels of activation are necessary for supporting the superficial progenitor population and lubricin expression (this work and refs [@R5], [@R7]).](annrheumdis-2015-208577f06){#ANNRHEUMDIS2015208577F6}

Discussion {#s4}
==========

We discovered that, whereas WNT16 is dispensable during joint embryonic morphogenesis, when other Wnts (WNT9a and WNT4) are also expressed within the joint interzones, its upregulation following injury in adult life is essential to preserve cartilage homeostasis. This likely occurs through the unique capacity of this WNT ligand to prevent excessive activation of the canonical WNT pathway by limiting the capacity of other more potent WNT ligands and by contributing to the upregulation of lubricin, an essential joint lubricant that protects chondrocytes from shear stress. Through activation of the canonical WNT pathway, WNT16 was a specific activator of lubricin since WNT3a was more potent in activating the canonical WNT pathway but far less potent in upregulating lubricin.

Recently, it was reported that WNT16 produced by osteoblasts supports cortical bone formation and bone homeostasis by inhibiting osteoclastogenesis.[@R25] Mutants lacking either exons 2 and 3 or the entire open-reading frame of *wnt16* gene displayed the same phenotype.[@R25] We originally backcrossed our mutants in the DBA/1 genetic background and also observed a high incidence of spontaneous fractures as described.[@R25] However, this was not observed in the 129/Sv genetic background, hence OA was induced in the 129/Sv background. It would have been interesting to investigate whether in the DBA/1 the OA phenotype was more severe due to the underlying bone phenotype. However, the lack of load on the knee due to the tibial fracture would have been a confounding element.

OA is a disease of the whole joint, and, in particular, the cartilage and bone form a functional unit that shares cellular and molecular homeostatic mechanisms.[@R31] It is interesting to note how loss of function of the WNT inhibitor FRZB was also associated with increased susceptibility to OA in mice[@R14] and humans,[@R15] but as opposed to WNT16-deficient mice, also with increased bone mass.[@R14] These data stress the importance of the interplay of the cartilage and bone functional unit in OA development.[@R31] Compared with FRZB, WNT16 has some agonist activity and this may explain the opposite phenotype in the bone. It would be interesting to understand the possible redundancies and the contribution of this agonistic activity in the context of joint homeostasis and the respective contribution of these two molecules.

Conditional WNT16 knockout (KO) in cartilage or bone will represent an opportunity to understand the specific roles of WNT16 and of these two tissues in the development of OA.

The fact that, following acute cartilage injury, FRZB is downregulated and WNT16 is upregulated suggests that this difference may play an important role following injury. It would be interesting to understand the possible redundancies and the contribution of this agonistic activity in the context of joint homeostasis and the respective contribution of these two molecules.

Lubricin is essential for joint homeostasis and its disruption results in cartilage breakdown associated with chondrocyte apoptosis, which was also seen in our model and was restricted to the superficial region of the articular cartilage. However, we also noticed that exogenous WNT16 modulated other markers of the SZCs, which produce lubricin. Recent data support the concept that SZCs represent specific progenitor cells in the articular cartilage[@R5] [@R6] and that they are mobilised to the site of cartilage damage following injury.[@R32] It is therefore possible that the increased susceptibility to OA of WNT16-deficient mice might be caused not just by the failure to upregulate lubricin following DMM, but by a more general phenotypic derangement of the SZCs, as suggested by the alteration in the expression of multiple markers when stimulated with WNT16. This likely occurs as a result of loss of controlled canonical WNT signalling as in development, the differentiation and maintenance of such important cell population is highly dependent on the maintenance of a balanced activation of canonical WNT signalling at the cartilage surface.[@R3]

The modulation of canonical WNT signalling by WNT16 is likely the most important element of novelty in this study. Movérare-Skrtic *et al*[@R25] reported that WNT16 is a weak agonist of the canonical WNT signalling. Here, we confirmed these data and add that it also functions as an inhibitor when administered together with more potent WNT proteins. Both excessive activation[@R8] [@R14] [@R15] or excessive suppression[@R6] [@R7] [@R16] [@R17] of WNT signalling causes cartilage loss in mice as well as in humans. Therefore, after injury, WNT16 may trigger controlled homeostatic responses, which, in the early phases of OA, have a chance to halt cartilage loss and ensure that the net activation of WNT signalling is sustained so as to allow maintenance of chondrogenic stem cells[@R4] but without exceeding the limits that would cause cartilage breakdown. This modality of signalling was not limited to the articular cartilage and OA but was extended to biological contexts as remote as Xenopus development. It is therefore likely that WNT16 may represent a 'buffering WNT' in several other contexts when WNT activation is desirable but excessive activation is not, such as in skin wound healing,[@R33] and provides an explanation of how a fine balance of WNT activation is achieved in highly dynamic biological contexts such as repair and homeostasis.
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